Exclusive Agreement Sample Contracts

Third Amendment to the Exclusive Agreement Between Abbott Point of Care Inc. And Abaxis, Inc. (August 9th, 2017)

This Third Amendment ("Third Amendment") to that certain Exclusive Agreement ("Agreement") dated as of October 26, 2012 is effective as of July 11, 2017 ("Third Amendment Effective Date") between Abaxis, Inc., ("ABAXIS") and Abbott Point of Care Inc., ("ABBOTT") relating to the appointment of ABBOTT to sell and distribute Abaxis Products. Any capitalized term used and not otherwise defined herein shall have the meaning set forth in the Agreement.

Second Amendment to the Exclusive Agreement Between Abbott Point of Care Inc. And Abaxis, Inc. (August 9th, 2017)

This Second Amendment ("Second Amendment") to that certain Exclusive Agreement ("Agreement") dated as of March 7, 2017, is effective as of April 19, 2017 ("Amendment Effective Date") between Abaxis, Inc. ("ABAXIS") and Abbott Point of Care Inc. ("ABBOTT") relating to the appointment of ABBOTT to sell and distribute Abaxis Products. Any capitalized term used and not otherwise defined herein shall have the meaning set forth in the Agreement.

Celladon Corp – Exclusive Agreement (December 14th, 2015)

This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and Eiccose, LLC (Eiccose), a Delaware limited liability company having a principal place of business at 1115 Lafayette Street, Santa Clara, CA 95050, is effective on the 27th day of October 2015 (Effective Date).

Celladon Corp – Exclusive Agreement (December 14th, 2015)

This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and Eiccose, LLC (Eiccose), a Delaware limited liability company having a principal place of business at 1115 Lafayette Street, Santa Clara, CA 95050, is effective on the 1st day of May 2015 (Effective Date).

First Amendment to Exclusive Agreement (October 7th, 2014)

This First Amendment, effective as of October 26, 2005, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the Exclusive Agreement between Stanford and Licensee, titled Restoration of Articular Cartilage Matrix dated April 15, 2001 and described in Stanford docket S98-181 (the Agreement). Stanford and Histogenics agree as follows:

Confidential Treatment Requested Second Amendment to Exclusive Agreement (October 7th, 2014)

This Second Amendment, effective as of January 15, 2006, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the April 15, 2001 agreement between Stanford and Licensee as follows:

Exclusive Agreement (October 7th, 2014)

Effective as of April 15, 2001 (Effective Date), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (STANFORD), and Histogenics Corporation, a Massachusetts corporation having a principal place of business at 116 Pleasant Street, Suite 19, Easthampton, Massachusetts, 01027 (LICENSEE), agree as follows:

Royal Bodycare – Exclusive Agreement (August 28th, 2014)

This agreement (the "Agreement") is made as of the 1st day of August, 2014, by and between RBC Life Sciences, Inc., a Nevada corporation with offices at 2301 Crown Court, Irving, Texas, 75038, USA, ("RBC" or "Supplier"), and Coral Club International Inc., an Ontario corporation, with offices at 255 Duncan Mill Road, Suite 806, Toronto, ON, M3B 3H9, Canada ("CCI" or "Purchaser").

CareDx, Inc. – Amended and Restated Exclusive Agreement (July 15th, 2014)

This Amended and Restated Agreement (Restated Agreement) between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and ImmuMetrix, Inc. (ImmuMetrix), a corporation having a principal place of business at 3183 Porter Drive, Palo Alto, CA, is effective on the 27th day of January, 2014, (Restatement Effective Date).

CareDx, Inc. – Amended and Restated Exclusive Agreement (June 3rd, 2014)

This Amended and Restated Agreement (Restated Agreement) between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and ImmuMetrix, Inc. (ImmuMetrix), a corporation having a principal place of business at 3183 Porter Drive, Palo Alto, CA, is effective on the 27th day of January, 2014, (Restatement Effective Date).

Confidential Treatment Requested Second Amendment to Exclusive Agreement (May 16th, 2014)

This Second Amendment, effective as of January 15, 2006, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the April 15, 2001 agreement between Stanford and Licensee as follows:

First Amendment to Exclusive Agreement (May 16th, 2014)

This First Amendment, effective as of October 26, 2005, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the Exclusive Agreement between Stanford and Licensee, titled Restoration of Articular Cartilage Matrix dated April 15, 2001 and described in Stanford docket S98-181 (the Agreement). Stanford and Histogenics agree as follows:

Exclusive Agreement (May 16th, 2014)

Effective as of April 15, 2001 (Effective Date), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (STANFORD), and Histogenics Corporation, a Massachusetts corporation having a principal place of business at 116 Pleasant Street, Suite 19, Easthampton, Massachusetts, 01027 (LICENSEE), agree as follows:

Exclusive Agreement (February 14th, 2014)

Effective as of April 15, 2001 (Effective Date), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (STANFORD), and Histogenics Corporation, a Massachusetts corporation having a principal place of business at 116 Pleasant Street, Suite 19, Easthampton, Massachusetts, 01027 (LICENSEE), agree as follows:

Confidential Treatment Requested First Amendment to Exclusive Agreement (February 14th, 2014)

This First Amendment, effective as of October 26, 2005, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the Exclusive Agreement between Stanford and Licensee, titled Restoration of Articular Cartilage Matrix dated April 15, 2001 and described in Stanford docket S98-181 (the Agreement). Stanford and Histogenics agree as follows:

Confidential Treatment Requested Second Amendment to Exclusive Agreement (February 14th, 2014)

This Second Amendment, effective as of January 15, 2006, by and between the Board of Trustees of the Leland Stanford Junior University, a body having corporate powers under the laws of the State of California (Stanford), and Histogenics Corporation, a Massachusetts corporation (Histogenics), serves to amend the April 15, 2001 agreement between Stanford and Licensee as follows:

Amendment to Exclusive Agreement (November 12th, 2013)

THIS AMENDMENT (this "Amendment"') of that certain Exclusive Agreement, dated as of October 26, 2012 ("Original Agreement"), by and between Abbott Point of Care Inc. and Abaxis, Inc., is effective as of September 30, 2013 ("Amendment Effective Date"). Capitalized terms used but not defined herein have the meanings given them in the Original Agreement.

Exclusive Agreement (July 2nd, 2013)

THIS EXCLUSIVE AGREEMENT ("Agreement") is made and entered into on October 26, 2012 by and between Abbott Point of Care Inc., a Delaware corporation, having its principal place of business at 400 College Road East, Princeton, NJ 08540 ("Abbott"), and Abaxis, Inc., a Delaware corporation with offices at 3240 Whipple Road, Union City, CA 94587 ("Abaxis"), and effective as of January 2, 2013 ("Effective Date"). Abbott and Abaxis are sometimes referred to herein individually as a "Party" and collectively as the "Parties".

Exclusive Agreement (February 11th, 2013)

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Software Professionals – Dated the 26th Day of October, 2009 THE SUGAR CANE PAPER COMPANY LIMITED (Principal) and SUGAR MADE, INC. (Agent) NORTH AMERICA/EUROPE EXCLUSIVE AGREEMENT (December 29th, 2011)
Confidential Treatment Requested Exclusive Agreement for Sale and Implementation of Specified Signs With Price (August 9th, 2011)

This Exclusive Agreement For Sale and Placement of Specified Signs with Price (this Agreement) is entered into effective as of April 15, 2011, by and between Insignia Systems, Inc. (Insignia), and News America Marketing In-Store Services L.L.C. (NAM) and News America Marketing Properties, LLC (NAMP).

Biovest International – Exclusive Agreement (February 15th, 2011)

This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and BioVest International, Inc. (BioVest), a corporation having a principal place of business at 8500 Evergreen Boulevard NW, Minneapolis, MN 55433, is effective on the 17 day of September, 2004 (Effective Date).

WNS Studios, Inc. – Exclusive Agreement (February 3rd, 2011)

THIS EXCLUSIVE AGREEMENT is made as of May 16, 2009 (this "Agreement") by and between WNS Studios, Inc., a Nevada corporation having an office 3811 13th Avenue, Brooklyn, NY 11218 (the "Agent") and Watermark Studios, Inc., a Nevada corporation having its principal place of business at 930 Washington Avenue, Suite 1A, Muskegon, MI 49441 (the "Studio"). font>

Biofield Cp New – Exclusive Agreement for License and Transfer of Ip (August 16th, 2010)

THIS AGREEMENT is made and entered into as of the date last entered below and upon the payment of $250,000 to Guided Therapeutics, Inc. ("GT") (as set forth below), which payment must be made to GT no later than January 30, 2011 and $20,000 to GT for previous services provided, which payment must be made to GT by no later than August 15, 2010 ("the Effective Date"), by and between Mark L. Faupel, Ph.D., an individual having an address of 160 Foalgarth Way, Alpharetta, Georgia 30022 ("DR. FAUPEL") and Biofield Corp., a Delaware corporation, having an office at 175 Strafford Avenue, Wayne, PA 19087 ("BZEC").

News Release Photo Release Capstone Acquires Calnetix Power Solutions 100kW Microturbine Business and Enters Into an Exclusive Agreement to Distribute the 125kW Zero Emission Waste Heat Recovery Generator (February 5th, 2010)

CHATSWORTH, Calif., Feb 2, 2010 (GlobeNewswire via COMTEX) Capstone Turbine Corporation (www.capstoneturbine.com)(Nasdaq:CPST), the worlds leading clean technology manufacturer of microturbine energy systems, today announced it has acquired the TA100 microturbine product line from Calnetix Power Solutions, Inc. (CPS) and entered into a Manufacturing Sub-contract agreement and an Original Equipment Manufacturer (OEM) agreement with selected exclusive rights to package a combined microturbine and Waste Heat Recovery Generator (WHG) product.

Exclusive Agreement (August 10th, 2009)

THIS EXCLUSIVE AGREEMENT (Agreement) is made and entered into by and between Abbott Point of Care Inc., a Delaware corporation, having its principal place of business at 400 College Road East, Princeton, NJ 08540 (Abbott), and Abaxis, Inc., a Delaware corporation with offices at 3240 Whipple Road, Union City, CA 94587 (Abaxis), and effective as of May 1, 2009 (Effective Date).

Aquablue International, Inc. – Exclusive Agreement on the Purchase, Distribution and Marketing of Bottled Spring Water in Hong Kong, Macao and Provinces of China to Be Named Later (June 29th, 2009)

AQUABLUE SPRING WATER INTERNATIONAL, INC. a Canadian corporation having its head office at 507 Place d'Armes, Suite 1550 Montreal (Quebec) CANADA H2Y 2W8

Amendment No. 1 to Loan Agreement (August 26th, 2008)

This Amendment No. 1 ("Amendment") to the Loan Agreement dated June 25, 2007 ("Agreement") is made and entered into on August 22, 2008, by and between Vault Technology, Inc., a Nevada corporation ("Maker"), and Caelum Finance Ltd. ("Lender").

Exclusive Agreement (August 19th, 2008)

This Exclusive Agreement ("Agreement") by and between LASERLOCK TECHNOLOGIES ("LL") located at 837 Lindy Lane, Bala Cynwyd, PA 19004 and ARTHUR BLANK & COMPANY, INC., ("AB") located at 225 Rivermoor Street, Boston, MA 02132 is entered into this 23rd day of June, 2008.

Mopie (Bvi) Ltd – Exclusive Agreement on the Option of Transfer of Shares of Shanghai Mopietek Information Technology Co., Ltd. Between Shi Yongmei Song Zhiling Shanghai Mopietek Information Technology Co., Ltd. And Shanghai Information Technology (Molong) Co., Ltd. Dated This July 1, 2007 (August 13th, 2008)

This Exclusive Agreement on Option of Share Transfer ("this Agreement") is executed by and between the parties below on July 1st 2007 in Shanghai, People's Republic of China ("China" or "PRC"):

YAHOO! TO STRENGTHEN COMPETITIVE POSITION IN ONLINE ADVERTISING THROUGH NON- EXCLUSIVE AGREEMENT WITH GOOGLE Agreement Advances Yahoo!s Open Strategy; Enhances Ability to Compete in Converging Search and Display Marketplace (June 13th, 2008)

Sunnyvale, CA, June 12, 2008 Yahoo! Inc. (Nasdaq: YHOO), a leading global Internet company, announced today that it has reached an agreement with Google Inc. that will enhance its ability to compete in the converging search and display marketplace, advancing the companys open strategy. The agreement enables Yahoo! to run ads supplied by Google alongside Yahoo!s search results and on some of its web properties in the United States and Canada. The agreement is non-exclusive, giving Yahoo! the ability to display paid search results from Google, other third parties, and Yahoo!s own Panama marketplace.

BioTrove – Exclusive Agreement (May 28th, 2008)

This Agreement between THE BOARD OF TRUSTEES OF THE LELANDAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and BioTrove, Inc. (BioTrove), a corporation having a principal place of business at 12 Gill Street, Suite 4000, Woburn, MA 01801, is effective on the 6th day of May, 2004 (Effective Date).

BioTrove – Exclusive Agreement (April 1st, 2008)

This Agreement between THE BOARD OF TRUSTEES OF THE LELANDAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and BioTrove, Inc. (BioTrove), a corporation having a principal place of business at 12 Gill Street, Suite 4000, Woburn, MA 01801, is effective on the 6th day of May, 2004 (Effective Date).

VIA Pharmaceuticals – Exclusive Agreement (August 14th, 2007)

This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford), an institution of higher education having powers under the laws of the State of California, and VIA Pharmaceuticals (VIA), a Delaware corporation having a principal place of business at 750 Battery Street, Suite 400, San Francisco, CA 94111, is effective on the 28th day of February, 2005 (Effective Date).

Gentherm – AMERIGON SUBSIDIARY BSST TO BROADEN THERMOELECTRIC TECHNOLOGY DEVELOPMENT WITH AUTOMOTIVE SUPPLIERS Modifies Exclusive Agreement With Visteon Corporation (July 5th, 2007)

NORTHVILLE, MI (July 3, 2007) . . . Amerigon Incorporated (Nasdaq:ARGN), a leader in developing and marketing products based on advanced thermoelectric (TE) technologies for a wide range of global markets and applications, announced today that its subsidiary, BSST, reached agreement with Visteon Corporation (NYSE:VC) to modify their exclusive development agreement related to the Companys proprietary thermoelectric technology for automotive applications, permitting BSST to undertake further development with a limited number of additional development partners. Under the terms of the agreement, BSST will purchase certain Visteon rights to thermoelectric systems technology, grant Visteon a fully paid-up, royalty-free license to this technology, and have the ability to license the technology to a limited number of additional automotive suppliers.